ReviewActa physiologica (Oxford, England)2026
Signal Amplification in the HPT Axis-Evidence for Its Existence, Location, Significance, and Molecular Mechanisms.
Review in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Thyroid hormones (THs) are under negative feedback regulation via the hypothalamic-pituitary-thyroid (HPT) axis. How this axis operates to keep the circulating THs within a narrow physiological range is not well understood quantitatively. Led by the design principle of robust homeostatic feedback control, here we review and synthesize the literature under a unifying theme of signal amplification in the HPT axis, providing evidence for its existence, location, functional significance, and potential molecular mechanisms. Drawing on human studies of the circulating TSH-T4 relationship, we assert that a signal amplifier exists in the brain, where the TH feedback signal is amplified to inhibit TRH and TSH. With mathematical models we illustrate that placing the signal amplifier of the HPT feedback loop in the brain, not in the thyroid, provides an evolutionary advantage, which minimizes the disruption of operating TH levels by possible perturbations. We review the molecular neuroendocrine literature to reveal how signal amplification (ultrasensitivity) is likely achieved mechanically in the hypothalamus and anterior pituitary. We identify multiple signaling pathways in the TRH neurons, β2-tanycytes, and thyrotropes that mediate the feedback action of THs, including transcriptional and posttranslational regulations of the synthesis, maturation, degradation, and release of TRH and TSH. Collectively, these multistep regulations amplify T3 signal, providing a high feedback loop gain for robust TH homeostatic control. The nature's design principle revealed here enhances our cross-scale understanding of the systems biology of the HPT axis as a dynamical control system, which can promote precision thyroid medicine and risk assessment of thyroid-disrupting chemicals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.